PT Mitra Keluarga Karyasehat (MIKA) Q4 2025 earnings summary

Executive summary

• Leading Indonesian hospital group with 33 hospitals and clinics, strong operational excellence, and a proven track record of ramping up new hospitals.

• Focused on Greater Jakarta and Surabaya, regions with attractive demographics and high GDP contribution.

• High doctor retention rate and ability to attract top-tier healthcare professionals.

• Recognized for market dominance, elite patient outcomes, and award-winning ESG practices.

• Consolidated financial statements for 2025 and 2024 were audited and received an unqualified opinion, confirming fair presentation in accordance with Indonesian Financial Accounting Standards.

• The Group operates in healthcare services through multiple subsidiaries and hospitals across major Indonesian cities.

• Management asserts responsibility for the accuracy and completeness of the financial statements and internal controls.

Financial highlights

• Revenue grew 10.1% year-over-year to IDR 5.37 trillion for FY2025.

• Net income increased 17.5% year-over-year to IDR 1.44 trillion, with net margin rising to 26.9%.

• EBITDA rose 13.3% to IDR 2.09 trillion, with EBITDA margin at 38.8%.

• Cash and cash equivalents more than doubled to IDR 2.54 trillion.

• Total assets increased 12.4% to IDR 9.27 trillion.

• Gross profit rose to Rp2.94 trillion in 2025 from Rp2.62 trillion in 2024.

• Total equity attributable to owners increased to Rp7.25 trillion in 2025 from Rp6.50 trillion in 2024.

Outlook and guidance

• Pipeline of seven new hospitals under development, targeting over 1,400 additional beds.

• Two new hospitals opening in West Java in 2025, each with 100+ beds.

• Continued focus on expanding high-complexity specialty services and private patient segment.

• The Group continues to expand its hospital network and invest in healthcare infrastructure, with several construction projects in progress and expected completion in 2026.

• Management maintains a prudent approach to liquidity and capital structure, aiming to support future growth and maximize shareholder value.